Circadian rhythms in the pharmacokinetics and clinical effects of beta- agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma

Chronobiology International

Volumn 16, Issue 5, 1999, Pages 663-682

  D'Alonzo, Gilbert E ^a,c   Crocetti, Joseph G ^a   Smolensky, Michael H ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Anticholinergics; Beta agonists; Chronotherapy; Nocturnal asthma; Theophylline

Indexed keywords

ADRENALIN; ATROPINE; BAMBUTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FORMOTEROL; IPRATROPIUM BROMIDE; ISOPRENALINE; ORCIPRENALINE; PLACEBO; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SALMETEROL XINAFOATE; TELENZEPINE; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ARTICLE; ASTHMA; CHRONOTHERAPY; CIRCADIAN RHYTHM; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; ORAL DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

EID: 0032881994     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.3109/07420529908998734     Document Type: Article

References (79)

1. Arvidsson P, Larsson S, Lofdahl CG, et al. 1991. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J. 4:1168-73.
2. 2-adrenergic agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol. 104:665-71.
3. Barnes PJ, Fitzgerald GA, Dollery CT. 1982. Circadian variation in adrenergic response in asthmatic subjects. Clin Sci. 62:349-54.
4. Barnes PJ, Pauwels RA. 1994. Theophylline in the management of asthma: time for reappraisal? Eur Respir J. 7:579-91.
5. Bogin RM, Ballard RD. 1992. Treatment of nocturnal asthma with pulse-release albuterol. Chest. 102:362-66.
6. Bollinger AM, Young KYL, Gambertoglio JG, et al. 1989. Influence of food on the absorption of albuterol Rapatabs. J Allergy Clin Immunol. 83:123-26.
7. Brambilla C, Chastang C, Georges D, et al. 1994. Salmeterol compared with slow-release terbutaline in nocturnal asthma. Allergy. 49:421-26.
8. Britton MG, Earnshaw JS, Palmer JBD. 1992. A 12 month comparison of salmeterol and salbutamol in asthmatic patients. Eur Respir J. 5:1062-67.
9. Brown A, Smolensky M, D'Alonzo G, et al. 1988. Circadian chronesthesy of the airways of healthy adults to the β-agonist bronchodilator isoproterenol. Annu Rev Chronopharmocol. 5:163-66.
10. Catterall JL, Rhind GB, Whyte KF, et al. 1988. Is nocturnal asthma caused by changes in airway cholinergic activity? Thorax. 43:720-24.
11. Cazzola M, Matera MG, Liccardi G. 1994. Effect of telenzepine, an MI-selective muscarinic receptor antagonist, in patients with nocturnal asthma. Pulm Pharmacol. 7: 91-97.
12. Coe CI, Bames PJ. 1986. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest. 90:485-88.
13. Cox ID, Hughes DTD, McConnell K. 1984. Ipratropium bromide in patients with nocturnal asthma. Postgrad Med J. 60:526-28.
14. Creemers JD. 1988. A multicenter comparative study of salbuterol controlled release (Volmax) and sustained-release theophyllin (Theo-Dur) in the control of nocturnal asthma [abstract]. Eur Respir J. 1(suppl 2):333s.
15. D'Alonzo GE, Natim RA, Henochowicz S, et al. 1994. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA. 271: 1412-16.
16. D'Alonzo GE, Smolensky MH, Feldman S, et al. 1989. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning versus evening administration. Chest. 107:406-12.
17. D'Alonzo GE, Smolensky MH, Feldman S, et al. 1990. Twenty-four hour lung function in adult patients with asthma: chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing. Am Rev Respir Dis. 142:84-90.
18. Dorow P, Steinijans VW. 1987. Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma. Chronobiol Int. 4:349-57.
19. Eriksson L, Jonson B, Eklundh G, et al. 1988. Nocturnal asthma: effects of slow-release terbutaline on spirometry and arterial blood gases. Eur Respir J. 1:302-5.
20. Eriksson NE, Haglind K, Ljungholm K. 1982. A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma. Br J Dis Chest. 76:202-4.
21. Faurschou P, Engel AM, Haanaes OC. 1994. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Allergy. 49:827-32.
22. Fitzgerald GA, Barnes P, Brown MN, et al. 1980. The circadian variability of circulating adrenaline and bronchomotor reactivity in asthma. In: Smolensky MH, Reinberg A, Labrecque G, editors. Recent advances in chronobiology of allergy and immunology. Pergamon: Oxford, pp. 89-94.
23. Fitzpatrick MF, Mackay T, Driver H, et al. 1990. Salmeterol in nocturnal asthma: a double-blind, placebo controlled trial of a long acting inhaled P2 agonist. Br Med J. 301:1365-68.
24. Gaultier C, Reinberg A, Girard F. 1975. Circadian changes in lung resistance and dynamic compliance in healthy and asthmatic children. Effects of two bronchodilators. Resp Physiol. 31:169-82.
25. Gaultier C, Reinberg A, Motohashi Y. 1988. Circadian rhythm in total pulmonary resistance of asthmatic children. Effects of a β-agonist agent. Chronobiol Int. 5: 285-90.
26. Grossman J, Morris RJ, White KD, et al. 1991. Improved stability in oral delivery of albuterol provides less variability in bronchodilation in adults with asthma. Ann Allergy. 66:324-27.
27. Gunn SD, Ayres JG, McConchie SM. 1995. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group. Eur J Clin Pharmacol. 48:23-28.
28. Harter JG, Reddy WIJ, Thorn GW. 1963. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med. 296:591-95.
29. Helms S. 1987. Diurnal stabilization of asthma with once daily evening administration of controlled release theophylline. Immunol Allergy Pract 9:414-19.
30. Higenbottam MA, Khan A, Williams DO, et al. 1989. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction. J Int Med Res. 17:435-41.
31. Hrushesky WJM, Langer R, Theeuwes F (editors). 1991. Temporal control of drug delivery. Ann NY Acad Sci. 618.
32. Hussey EK, Donn KH, Powell JR. 1991. Albuterol extended-release products: a comparison of steady-state pharmacokinetics. Pharmacotherapy. 11:131-35.
33. Joad JP, Ahrens RC, Lindgren SD, et al. 1987. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J Allergy Clin Immunol. 79:78-85.
34. Johnson M. 1991. The preclinical pharmacology of salmeterol: bronchodilator effects. Eur Respir Rev. 1:253-56.
35. Kemp JP, Bierman CW, Cocchetto DM. 1993. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring. Ann Allergy. 70:316-22.
36. Kesten S, Chapman KR, Broder I, et al. 1992. Sustained improvement in asthma with long-term use of formoterol fumarate. Ann Allergy. 69:415-20.
37. Kidney JC, Dominguez M, Rose M, et al. 1994. Withdrawing chronic theophylline treatment increases airway lymphocytes in asthma. Thorax. 49:396.
38. Koeter GH, Postma DS, Keyzer JJ, et al. 1985. Effect of oral slow-release terbutaline on early morning dyspnea. Eur J Clin Pharmacol. 28:159-62.
39. Kraft M, Torvik JA, Trudeau J, et al. 1996. Theophylline potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin. Irnmunol. 97:1242-46.
40. Kyle GM, Smolensky MH, McGovern JP. 1979. Circadian variation in the susceptibility of rodents to the toxic effects of theophylline. In: Reinberg A, Halberg F, editors. Chronopharmacology. Oxford, England: Pergamon, pp. 239-44.
41. Lemmer B (editor). 1989. Chronopharmacology. Cellular and biochemical interactions. New York: Marcel Dekker.
42. Lundback B, Rawlinson DW, Palmer JBD. 1993. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax. 48: 148-53.
43. Maesen FPV, Smeets JJ. 1986. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease. Eur Respir J. 31:431-36.
44. Maesen FPV, Smeets JJ, Gubbelmans HLL, et al. 1990a. Bronchodilator effect of inhaled formoterol versus salbutamol over 12 hours. Chest. 97:590-94.
45. Maesen FPV, Smeets JJ, Gubbelmans HLL, et al. 1990b. Formoterol in the treatment of nocturnal asthma. Chest. 98:866-70.
46. Moore-Gillon J. 1988. Volmax (salbutamol CR 8 mg) in the management of nocturnal asthma: a placebo-controlled study [abstract]. Eur Respir J. 1(suppl 2):306s.
47. Morrison JFJ, Pearson SB, Dean HG. 1988. Parasympathetic nervous system in nocturnal asthma. Br Med J. 296:1427-29.
48. Muir JF, Bertin L, Georges D. 1992. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. Eur Respir J. 5:1197-1200.
49. National Asthma Education and Prevention Program. 1997. Expert Panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, Maryland: National Institutes of Health, publication no. 97-4051.
50. National Heart, Lung, and Blood Institute. 1992. International consensus report on diagnosis and management of asthma. Bethesda, Maryland: National Institutes of Health, publication no. 92-3091.
51. National Heart, Lung, and Blood Institute and World Health Organization. 1995. Global initiative for asthma. Bethesda, Maryland: National Institutes of Health, publication no. 95-3659.
52. Neuenkirchen H, Wikens JH, Oellerich M, et al. 1985. Nocturnal asthma: effect of a once per evening dose of sustained-release theophylline. Eur J Respir Dis. 66: 196-204.
53. O'Connor BJ, Towse LJ, Barnes PJ. 1996. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med. 154(4, pt 1):876-80.
54. Pearlman DS, Chervinsky P, LaForce C, et al. 1992. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med. 327: 1420-25.
55. Pedersen BK, Laursen LC, Gnosspelius Y, et al. 1985. Bambuterol: effects of a new antiasthmatic drug. Eur J Clin Pharmacol. 29:425-27.
56. Persson G, Gnosspelius Y, Anehus S. 1988. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice-daily. Eur Respir J. 1:223-26.
57. Petrie GR, Chookang JY, Hassan WU, et al. 1993. Bambuterol: effective in nocturnal asthma. Respir Med. 87:581-85.
58. Pierson WE, LaForce CF, Bell TD, et al. 1990. Long-term, double blind comparisons of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol. 85:618-26.
59. Postma DS, Koeter GH, Keyzer JJ. 1986. Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction. J Allergy Clin Immunol. 77: 471-477.
60. Postma DS, Koeter GH, v.d. Mark TW, et al. 1985. The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest. 87:653-57.
61. Powell ML, Weisberger M, Dowdy Y, et al. 1987. Comparative steady-state bioavailability of conventional and controlled-release formulation of albuterol. Biopharm Drug Dispos. 8:461-67.
62. Redfern P, Lemmer B (editors). 1997. Physiology and pharmacology of biological rhythms. Heidelberg: Springer-Verlag.
63. Reinberg A, Pauchet F, Ruff F, et al. 1987. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Int. 4:409-20.
64. Schulz H-U, Frercks H-J, Hypa F. 1984. Vergleichende Theophyllin-Serum-Spiegel Messungen uber 24 stunden nach konventioneller Dosierung ciner Theophyllin-retard-Präparation über 4 Tage. Therapie Woche. 34:536-43.
65. Selby C, Engleman HM, Fitzpatrick MF, et al. 1997. Inhaled salmeterol or oral theophylline in nocturnal asthma? Am J Respir Crit Care Med. 155(1):104-8.
66. Smolensky MH. 1989. Chronopharmacology of theophylline and beta-sympathomimetics. In: Lemmer B, editor. Chronopharmacology. Cellular and biochemical interactions New York: Marcel Dekker, pp. 65-113.
67. Smolensky MH, McGovern JP, Scott PH, et al. 1987. Chronobiology and asthma. 11. Body-time-dependent differences in the kinetics and effects of bronchodilator medications. J Asthma. 24:90-134.
68. Smolensky MH, Scott PH, Harrist RB, et al. 1987. Administration-time dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children. Chronobiol Int. 4:435-48.
69. Storms WW, Nathan RA, Bodman SF, et al. 1992. The effects of repeat action albuterol sulfate (Proventil Repetabs) in nocturnal symptoms of asthma. J Asthma. 29: 209-16.
70. Sullivan P, Songul B, Jaffar Z, et al. 1994. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet. 343:1006-8.
71. Sykes RS, Reese ME, Meyer MC, et al. 1988. Relative bioavailability of a controlled-release albuterol formation for twice-daily use. Biopharm Drug Dispos. 9:551-56.
72. Torvik JA, Borish LC, Beam WR, et al. 1994. Does theophylline alter inflammation in nocturnal asthma? [abstract]. Am J Respir Crit Care Med. 149:A210.
73. Trudeau JB, Martin RJ, Kraft M, et al. 1994. Theophylline decreases stimulated alveolar macrophage leukotriene B4 (LTB4) production in nocturnal asthmatics lavaged at 4 A.M [abstract]. Am J Respir Crit. Care Med. 149:A941.
74. Ullman A, Hedner J, Svedmyr N. 1990. Inhaled salmeterol and salbutamol in asthmatic patients. Am Rev Resp Dis. 142:571-75.
75. 2-adrenorceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax. 43: 674-78.
76. Van Keimpema AR, Ariaansz M, Raaijmakers JA, et al. 1996. Treatment of nocturnal asthma by addition of oral slow-release albuterol to standard treatment in stable asthma patients. J Asthma. 33:119-24.
77. Ward AJM, McKenniff M, Evans JM, et al. 1993. Theophylline: an immunomodulatory role in asthma? Am Rev Respir Dis. 147:518-23.
78. Weersink EJ, Dourna RR, Postma DS, et al. 1997. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma. Am J Respir Crit Care Med. 155(4):1241-46.
79. Wolstenholme RJ, Shettan SR 1989. Comparison of a combination of fenoterol with ipratropium bromide (Duovent) and salbutamol in young adults with nocturnal asthma. Respiration. 55:152-57.